Correlation Between Alphabet and Ocuphire Pharma
Can any of the company-specific risk be diversified away by investing in both Alphabet and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Ocuphire Pharma, you can compare the effects of market volatilities on Alphabet and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Ocuphire Pharma.
Diversification Opportunities for Alphabet and Ocuphire Pharma
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alphabet and Ocuphire is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of Alphabet i.e., Alphabet and Ocuphire Pharma go up and down completely randomly.
Pair Corralation between Alphabet and Ocuphire Pharma
Given the investment horizon of 90 days Alphabet Inc Class C is expected to generate 0.33 times more return on investment than Ocuphire Pharma. However, Alphabet Inc Class C is 3.07 times less risky than Ocuphire Pharma. It trades about 0.04 of its potential returns per unit of risk. Ocuphire Pharma is currently generating about -0.58 per unit of risk. If you would invest 16,453 in Alphabet Inc Class C on August 25, 2024 and sell it today you would earn a total of 204.00 from holding Alphabet Inc Class C or generate 1.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 13.64% |
| Values | Daily Returns |
Alphabet Inc Class C vs. Ocuphire Pharma
Performance |
| Timeline |
| Alphabet Class C |
| Ocuphire Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Alphabet and Ocuphire Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alphabet and Ocuphire Pharma
The main advantage of trading using opposite Alphabet and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.The idea behind Alphabet Inc Class C and Ocuphire Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Ocuphire Pharma vs. Reviva Pharmaceuticals Holdings | Ocuphire Pharma vs. Protalix Biotherapeutics | Ocuphire Pharma vs. Eyepoint Pharmaceuticals | Ocuphire Pharma vs. Sellas Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |